Mark Singleton
Officer at GreenLight Biosciences Holdings, PBC (GRNA)
Mark Singleton has filed 2 insider reports with the SEC since February 2022, as officer at GreenLight Biosciences Holdings, PBC (GRNA) and officer at GreenLight Biosciences Holdings, PBC (ENVI). The latest filing, on August 8, 2022, reports grant or award at GreenLight Biosciences Holdings, PBC (GRNA).
- Filings
- 2
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Mark Singleton is an insider
| Company | Role | Shares held | Bought | Sold | Last filing |
|---|---|---|---|---|---|
| GRNA GreenLight Biosciences Holdings, PBC | Officer | Aug 8, 2022 | |||
| ENVI GreenLight Biosciences Holdings, PBC | Officer | Feb 5, 2022 |
Shares held: common shares owned directly after the latest filing that states it.
Every filing
- May 10, 2022GRNASEC Form 4 filed by Singleton MarkForm 4Grant or award
- Feb 2, 2022ENVISEC Form 4 filed by Singleton MarkForm 4Grant or award
Questions about Mark Singleton
- What is Mark Singleton's role at GreenLight Biosciences Holdings, PBC?
- Mark Singleton reports to the SEC as officer at GreenLight Biosciences Holdings, PBC (GRNA), according to the latest filing on August 8, 2022. Mark Singleton has also filed as officer at GreenLight Biosciences Holdings, PBC (ENVI).
- Has Mark Singleton bought or sold stock recently?
- No open-market purchases or sales by Mark Singleton are on file. The filings report grant or award.
- How do I get alerts when Mark Singleton files?
- Follow Mark Singleton on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5.
From SEC Forms 4 and 5 filed by Mark Singleton (SEC CIK 0001908629). Totals count each trade once, skipping amendments whose original is on file, from Feb 5, 2022 on. View on SEC EDGAR